IAA (NYSE:IAA) Stock Rating Upgraded by CJS Securities

Share on StockTwits

CJS Securities upgraded shares of IAA (NYSE:IAA) to a buy rating in a report issued on Wednesday morning, TipRanks reports. CJS Securities currently has $51.00 price target on the stock.

IAA has been the topic of several other research reports. Jefferies Financial Group initiated coverage on shares of IAA in a research note on Wednesday, July 31st. They issued a buy rating and a $55.00 price objective on the stock. Zacks Investment Research upgraded shares of IAA from a sell rating to a hold rating in a research note on Tuesday, November 12th. Barrington Research restated a hold rating on shares of IAA in a research note on Thursday, September 12th. SunTrust Banks restated a buy rating and issued a $53.00 price objective on shares of IAA in a research note on Wednesday, August 14th. Finally, Stephens restated an overweight rating and issued a $51.00 price objective (up previously from $47.00) on shares of IAA in a research note on Wednesday. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The stock presently has a consensus rating of Buy and an average target price of $50.71.

Shares of IAA stock traded down $0.17 during midday trading on Wednesday, hitting $42.28. The company had a trading volume of 663,299 shares, compared to its average volume of 1,247,321. The company’s 50 day moving average price is $39.29. IAA has a 1-year low of $34.96 and a 1-year high of $49.96.

IAA (NYSE:IAA) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.02. The company had revenue of $357.30 million during the quarter, compared to analyst estimates of $347.31 million. The company’s revenue was up 11.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.33 EPS. On average, analysts anticipate that IAA will post 1.59 earnings per share for the current year.

Institutional investors and hedge funds have recently bought and sold shares of the business. Advisor Group Inc. acquired a new stake in IAA during the second quarter worth $28,000. Riverview Trust Co acquired a new stake in IAA during the third quarter worth $29,000. Harel Insurance Investments & Financial Services Ltd. acquired a new stake in IAA during the second quarter worth $33,000. FTB Advisors Inc. acquired a new stake in IAA during the second quarter worth $34,000. Finally, Crewe Advisors LLC acquired a new stake in IAA during the second quarter worth $34,000. Hedge funds and other institutional investors own 95.82% of the company’s stock.

About IAA

IAA, Inc provides salvage vehicle auctions and related services. It offers salvage auction services, such as inbound transportation logistics, inspection, evaluation, salvage recovery, titling, and settlement administrative services. The company's salvage auctions facilitate the remarketing of damaged vehicles designated as total losses by insurance companies, charity donation vehicles, recovered stolen (or theft) vehicles, and low value used vehicles through live and online auctions.

Recommended Story: Inverted Yield Curve

Analyst Recommendations for IAA (NYSE:IAA)

Receive News & Ratings for IAA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IAA and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Mcashchain Hits 1-Day Trading Volume of $66,230.00
Mcashchain Hits 1-Day Trading Volume of $66,230.00
ERC20  Trading 7.2% Lower  Over Last Week
ERC20 Trading 7.2% Lower Over Last Week
Zeepin 24-Hour Trading Volume Reaches $24.00
Zeepin 24-Hour Trading Volume Reaches $24.00
Analysts Anticipate CymaBay Therapeutics Inc  to Post -$0.38 Earnings Per Share
Analysts Anticipate CymaBay Therapeutics Inc to Post -$0.38 Earnings Per Share
Brokerages Set Coeur Mining Inc  Price Target at $5.97
Brokerages Set Coeur Mining Inc Price Target at $5.97
Cantor Fitzgerald Raises Sarepta Therapeutics  Price Target to $211.00
Cantor Fitzgerald Raises Sarepta Therapeutics Price Target to $211.00


© 2006-2019 Ticker Report